Dolby Executive's $1.85M Stock Sale Follows Recent $2.5M June Disposal
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
Dolby Laboratories (DLB) insider filing reports planned sale of 25,000 shares of common stock with an aggregate market value of $1,850,530. The securities were acquired through a stock option exercise on June 24, 2025, and are planned to be sold through Morgan Stanley Smith Barney LLC on the NYSE.
The filing also discloses recent trading activity by the Yeaman Family Trust, which sold:
- 25,000 shares for gross proceeds of $1,905,650 on June 10, 2025
- 8,683 shares for gross proceeds of $661,829 on June 10, 2025
This Form 144 represents a notice of proposed sale of securities pursuant to Rule 144 under the Securities Act of 1933. The total shares to be sold represent approximately 0.026% of Dolby's outstanding shares (96,066,188 shares).
Positive
- None.
Negative
- Insider selling pattern: Multiple sales by the Yeaman Family Trust totaling 33,683 shares worth approximately $2.57M in June 2025, followed by another planned sale of 25,000 shares worth $1.85M
- The aggregate insider sales within a short period (approximately $4.42M total) could signal reduced confidence in near-term stock performance
FAQ
What was the recent trading activity by the Yeaman Family Trust for DLB stock?
The Yeaman Family Trust made two sales of DLB stock on June 10, 2025: one sale of 25,000 shares for gross proceeds of $1,905,650.00, and another sale of 8,683 shares for gross proceeds of $661,828.68.